– RESET-RA is the first randomized, sham-controlled, double-blind trial to positively demonstrate the clinical potential of neuroimmune modulation for the treatment of rheumatoid arthritis (RA) – – ...

BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969), a leading biotech company, announced today that Professor Zhanguo Li, the leading PI, has presented latest data of BTK inhibitor orelabrutinib ...